Kamada’s Transferrin has potential for utilization in the pharmaceutical industry as a targeting molecule for highly metabolizing cells with high iron requirement (cancerous or infected) cells. Kamada, which has been producing and marketing industrial quantities of high purity human Transferrin (Tf) for tissue culture use, is planning to develop a pharmaceutical product given its proprietary know-how and expertise.